-->

Centaurus Financial - we invest in your success

financialbrowsers.com's Privacy Policy

We are strongly committed to protecting the privacy of every visitor to financialbrowsers.com. The following information is intended to help answer questions you may have about how we go about protecting every visitor's privacy.

financialbrowsers.com E-mail

Your name is the only required information for a FREE financialbrowsers.com E-mail address. Other information may be gathered. Legitimate requests or orders from courts or law enforcement agencies to obtain information will be complied with.

Disclosure

We do not use or disclose information about your individual visits to financialbrowsers.com or information that you may give us, such as your name, address, email address or telephone number, to any outside companies. We may share with our Web site partners aggregated statistical "ratings" information about the use of financialbrowsers.com. Legitimate requests or orders from courts or law enforcement agencies to obtain information will be complied with.

Contacting the Web Site

If you have any questions about this privacy statement, the practices of this site, or your dealings with financialbrowsers.com, use the link below to find out how to ask.

Contact Us

Home > Fortune 500 Companies > Mckesson Corporation

Mckesson Corporation

McKesson Corporation is a publicly traded company having a good stock performances result. It is the leading provider of supply, information and care management products and services designed to reduce costs and improve quality across healthcare. Mckesson Corporation is a Fortune 500 stock listed company trading under MCK symbol.

McKesson solutions empower healthcare professionals with the tools they need to deliver care more successfully and competently. It was established in 1833, with annual revenues of more than 80 billion dollars, they rank as the 16th largest industrial company in the United States.

John H. Hammergren is Chairman of McKesson Corporation. He has been a director of McKesson since 1999 and was elected President and Chief executive in 2001 and Chairman in 2002.United States pharmaceutical distribution business has added 40 billion dollars in sales, with almost no change in total headcount. During the same time, they have driven average annual volume per continental distribution center from less than 500 million to 1.6 billion dollars.

The company reported that revenues for the third quarter ended December 31, 2005 were 22.6 billion dollars, an increase of 9 percent over the prior year. Third quarter net income was 193 million dollars or 61 cents per diluted share, compared to 144 million dollars or 49 cents per diluted share excluding an after tax securities litigation charge of 810 million dollars in the third quarter a year ago. Including the securities litigation charge, in the third quarter last year they had a net loss of 666 million dollars or 2.26 dollars per basic share.

Operating cash flow remained strong at 1.48 billion dollars year to date. The company repurchased 290 million dollars of stock during the quarter leaving 129 million dollars remaining on a share repurchase program authorized in December 2005. For the first three quarters including securities proceeding charges and discontinued operations, they had net income of 531 million dollars or 1.69 dollars per diluted share compared to a net loss of 416 million dollars or 1.42 dollars per basic share a year ago.

Their reach of potentials coupled with one of the largest customer bases in the industry, facilitates them to reduce costs and optimize products and services. Customer satisfaction is their number one objective and they repeatedly invest in process improvements to meet that target.

Back to Fortune 500 Companies